Background {#Sec1}
==========

A series of pathological changes appear successively within 24 h after cerebral ischemia-reperfusion injury. These include pyknosis, degeneration, and edema of neurons and glial cells within 3 h, with cell death and edema peaking at 24 h \[[@CR1]\]. These changes were significantly correlated with factors like excessive free radical formation \[[@CR2]\], blood--brain barrier (BBB) damage \[[@CR3],[@CR4]\], amino acid excitotoxicity \[[@CR5]\], inflammatory response \[[@CR6]\], and intracellular calcium overload \[[@CR7],[@CR8]\].

In recent years, several reports have examined the time-course of the development of cerebral ischemia, so as to identify the underlying mechanisms. For example, ubiquitin + 1 immunoreactivity markedly increased 2 days after ischemia-reperfusion (I-R), but became very weak 5 days after I-R \[[@CR9]\]. The expression level of AQP-4 decreased quickly after focal cerebral I-R injury, reaching its lowest level 12--24 h after reperfusion; then it increased slowly, returning to its normal level 7 days after reperfusion \[[@CR10]\]. MMP-9 and gp91phox expression levels were up-regulated in the ischemic hemisphere of the brain tissue after 90 min of MCAO with 22.5 h of reperfusion \[[@CR11]\]. Glucokinase (GK) and glucokinase regulatory protein (GKRP) immunoreactivities in the pyramidal neurons were distinctively decreased in the hippocampal CA1 region, but not in CA2/3, 3 days after I-R. Five days after I-R, GK and GKRP immunoreactivities were hardly detectable in the CA1, but not in CA2/3, pyramidal neurons; however, at this point in time, GK and GKRP immunoreactivities were detected in astrocytes, not microglia, in the ischemic CA1 \[[@CR12]\]. The level of Vegfa mRNA increased in the rat brain, 4 h after occlusion in the cerebellum, cerebral cortex, and hippocampus, after 8 h in the cortex and hippocampus, and after 24 h in the cortex \[[@CR13]\].

Previous studies mostly focused on the role of a single molecule or protein. Due to the multifaceted pathomechanism of cerebral ischemia, it is unlikely that a single indicator is sufficient to influence the outcomes. Thus, a study on the time-dependent pathological mechanism evaluating the role of multiple molecules/proteins in cerebral ischemia is required. Our previous study probed the dynamic pathological mechanism and found several important genes and pathways within 24 h after cerebral I-R by analyzing the gene expression profiles of ischemia-reperfusion and pathways from the KEGG database at 3 h, 12 h, and 24 h in the hippocampus of ischemic mice \[[@CR14]\]. However, that study paid more attention to individual genes and less attention to the pathways and networks where these genes were not involved. The current study analyzes the mechanism of the pathological changes within 24 h after cerebral ischemia-reperfusion injury in the context of pathways and networks of protein molecules. The GeneGo MetaCore^TM^ software, with its high-quality and manually-curated databases, was used to integrate and visualize the data to glean information about signaling and metabolic pathways and the effects of bioactive molecules \[[@CR15]-[@CR17]\].

Methods {#Sec2}
=======

Animal model {#Sec3}
------------

Animal experiments were carried out in accordance with the Prevention of Cruelty to Animals Act (1986) and the National Institute of Health Guideline on the Care and Use of Laboratory Animals for experimental procedures. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation, China Academy of Chinese Medical Sciences. One hundred and eighty healthy adult male Kunming mice, at 12 weeks of age (weight 38--48 g), were obtained from the Experimental Animal Center in Health Science Center of Peking University. They were randomly assigned into 4 groups: sham, ischemia-reperfused 3 h, ischemia-reperfused 12 h, and ischemia-reperfused 24 h. In the ischemia-reperfused 3 h, 12 h and 24 h groups, according to Hara's method \[[@CR18]\], the mice were subject to middle cerebral artery occlusion (MCAO) for 1.5 h with the use of an intraluminal filament technique, and then reperfused for 3 h, 12 h, and 24 h, respectively, so as to induce focal cerebral ischemia-reperfusion models. In the sham group, the external carotid artery (ECA) was surgically prepared for the insertion of the filament, but the filament was not inserted. A thermostatically controlled infrared lamp was used during the surgery to maintain body temperature at 37°C. Blood pressure, blood gas, brain temperature, EEG and glucose were monitored.

Histological analysis {#Sec4}
---------------------

Ten mice from each group were anesthetized with 10% chloral hydrate (i.p. 400 mg/kg) and perfused with 4% cold formaldehydum polymerisatum for 30 min. Then, the mice were executed to get the brains. The brains were further fixed in 4% paraformaldehyde for 24 h, and embedded in paraffin wax. The paraffin-embedded blocks were cut into a series of 5 μm-thick slices, and stained with 0.2% thionine. The hippocampus CA1 region was selected for observation.

Measurement of cerebral infarct size by TTC staining {#Sec5}
----------------------------------------------------

After reperfusion, another 14 mice from each group were applied to calculate the infarction volume. The brain was coronally sectioned to 2 mm-thick slices and stained with 1% 2, 3, 5-triphenyl tetrazolium chloride (TTC) in phosphate buffer (0.1 M, pH 7.4) for 30 min at 37°C. These slices were refrigerated in 4% formaldehyde in phosphate buffer for 30 min at 37°C with light-free. A digital camera (Color CCD camera TP-6001A, Topica Inc., Japan) was used to capture the images of these slices. The areas of the infarction region were calculated by a Pathology Image Analysis System (Topica Inc., Japan) and the ratio of the infarction volume to the total slice was noted.

RNA isolation {#Sec6}
-------------

The total RNA of the left hippocampus was extracted respectively from 9 mice from each group in TRIzol reagent according to the manufacturer's instructions. Then, an RNeasy Micro Kit (Qiagen, Valencia, CA) was used to further purify and concentrate RNA. The quality of RNA was evaluated by analyzing the 26S/18S ratio with Bioanalyzer microchip (Agilent, Palo Alto, CA).

Microarray {#Sec7}
----------

Hybridization was performed on a microarray containing 374 cDNAs derived from the cDNA Library (Invitrogen, Cat.1065-025) (Shanghai Biochip co., Ltd, China). Each clone was printed as three duplicate spots on a given chip. A single intensity value for each clone was generated through averaging the quadruplet after smoothing spline normalization. All clones used for production of the microarrays were sequence verified. Six to nine biological replicates for each group were hybridized. The RNA in the sham group was labeled with Cy3 dUTP, and others was labeled with Cy5 dUTP. Then the microarrays were hybridized, washed and dried by airing for scanning. Image files were processed using the Axon GenePix 4000B scanner (Axon, USA) and datasets were prepared according to the routine procedures using ArrayTrack software (FDA, USA).

Microarray data analysis {#Sec8}
------------------------

After robust multiarray analysis and normalization process by GeneSpring, all experimental data were uploaded to the ArrayTrack system (FDA, USA). A one-way analysis of variance (ANOVA) model and Significance Analysis of Microarrays (SAM) were conducted to compare the means of altered genes among different groups. The value on the mean of altered gene was calculated based on at least three independent microarrays. We set P \< 0.05 as the statistical significance cutoff. Genes with a p-value less than 0.05 and a fold change greater than 1.5 were applied for further analysis. The up-regulated or down-regulated differentially expressed gene was defined as the expression level of the gene greater than 1.5-fold or less than 0.5-fold, respectively.

Pathway analysis {#Sec9}
----------------

All of the differentially expressed genes were uploaded and mapped to GeneGo database in ArrayTrack system (FDA, USA), which included canonic pathway maps, process networks, gene interactions, and etc. The significance of association between these genes and the canonical pathway was measured in the following 2 ways: 1) a ratio calculated using the number of genes from the dataset that maps the pathway divided by the total number of genes that map to the canonical pathway; 2) a P-value, calculated by Fischer's Exact Test, determining the probability that the association between the genes and canonical pathway was explained by chance alone. The level of statistical significance was set at P \< 0.05. Finally, canonical pathways with a P \< 0.05 and a fold change \> 1.5 were screened and analyzed.

Network construction and network analysis {#Sec10}
-----------------------------------------

The differentially expressed genes list was uploaded to construct and visualize the representative networks for each group using GeneGo MetaCore™ in ArrayTrack System (FDA, USA). ^.^The networks were generated as the interactions (edges) connecting the input genes (nodes). The edges were derived from the genes which had annotated functional interactions in GeneGo database. Three algorithms were used to analyze the properties of the networks: (1) the direct interaction algorithm to map direct gene-gene interactions; (2) the shortest path algorithm to map the shortest path for interaction between differentially expressed genes; and (3) the analyze algorithm to deduce top scoring processes that are regulated by differentially expressed genes \[[@CR19]\]. Only the genes in the upload list were contained in the network.

Node degree calculation {#Sec11}
-----------------------

The node degree means the number of edge linked to the node directly in the network as well as the number of nodes linked to the node. We calculated the degree of node with the equation below:$$\documentclass[12pt]{minimal}
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Any node *і* in the network, *ki* is the degree of node *i*.

Similarity among the 3 h, 12 h, and 24 h groups {#Sec12}
-----------------------------------------------

The Jaccard similarity index was used to measure the degree of association among 3 h, 12 h, and 24 h groups. This index considered the similarity among 3 h, 12 h, and 24 h groups as the number of genes shared divided by the total number of genes present in either one of them. It may be expressed as follows:$$\documentclass[12pt]{minimal}
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Where A is the number of genes present at a time point; B is the number of genes present at another time point; and C is the number of genes present at both time points. The number of genes present in either of the diseases is given by A + B − C.

Results {#Sec13}
=======

Pathway map analysis of altered genes {#Sec14}
-------------------------------------

After assessing neuronal death at 3 h, 12 h and 24 h after reperfusion (pathological expressions among different groups listed in Additional file [1](#MOESM1){ref-type="media"}: Figure S1), the MetaCore™ pathway map analysis of the selected genes was used to identify the statistically significant pathways, based on the calculated P values. The genes activated at 3 h, 12 h, and 24 h are listed in Additional file [2](#MOESM2){ref-type="media"}: Table S1. A total of 14, 59, and 72 significantly expressed pathways were identified in the 3 h, 12 h, and 24 h groups, respectively. These included 2, 19, and 32 non-overlapping pathways in the 3 h, 12 h, and 24 h groups, respectively. Eight pathways were overlapped in all the three groups, and several pathways had an overlap between the 3 h and 12h groups (2 pathways), 12 h and 24 h groups (30 pathways), or 3 h and 24 h groups (2 pathways) (Figure [1](#Fig1){ref-type="fig"}a).Figure 1**Top ten pathways in 3 h, 12 h, and 24 h groups after cerebral ischemia-reperfusion injury. (a)** shows the number of overlapping as well as non-overlapping pathways in the 3 h, 12 h, and 24 h groups. The circles in red, blue, and green represent pathways in the 3 h, 12 h, and 24 h groups, respectively. **(b)** shows the names of the top ten pathways at 3 h, 12 h, and 24 h.

Amongst the top ten pathways in the 3 h, 12 h, and 24 h groups, 5, 4, and 6 non-overlapping pathways were identified, respectively. Only one overlapping pathway was identified among all the three groups, and several overlapping pathways were detected between the 3 h and 12 h groups (3 pathways), 12 h and 24 h groups (2 pathways), or 3 h and 24 h groups (1 pathway) (Figure [1](#Fig1){ref-type="fig"}b).

The dynamic change of the TNFR1 signaling pathway in 3 h, 12 h, and 24 h groups {#Sec15}
-------------------------------------------------------------------------------

The TNFR1 signaling pathway was activated across the 3 h, 12 h, and 24 h groups and incidentally, it was the top scoring pathway; however, its constituent genes varied. Across the 3 time points, jBid, tBid, Bid, and IKK-gamma were found to be consistently activated. At 12 h, FADD and FLASH were up-regulated. At 24 h, Caspase-2 and FLASH were up-regulated (Figure [2](#Fig2){ref-type="fig"}). Compared with the 3 h group, the 12 h and 24 h groups had more routes to reduce apoptosis response in the TNFR1 signaling pathway. The ceramide signaling pathway, which might reduce cell death, was activated at 12 h, while caspase cascade was activated rapidly at 24 h.Figure 2**Change in TNFR1 signaling pathway in 3 h, 12 h, and 24 h groups after cerebral ischemia-reperfusion injury.** Upward thermometers have red color and indicate up-regulated expression levels of the genes. The circles at the base of the thermometers in red, blue, and green represent significantly differential expressions in the 3 h, 12 h, and 24 h groups, respectively.

Process network analysis in 3 h, 12 h, and 24 h groups {#Sec16}
------------------------------------------------------

The top 10 cellular and molecular processes were defined and annotated by GeneGo. Each process represented a preset network of protein interactions characteristic of the process. A total of 4, 5, and 5 non-overlapping/unique processes were identified in the 3 h, 12 h, and 24 h groups, respectively. Two overlapping processes were identified among the three groups. Two, 1, and 2 processes were found to overlap between the paired groups of 3 h and 12 h, 12 h and 24 h, and 3 h and 24 h, respectively (Figure [3](#Fig3){ref-type="fig"}). Among the top 10 cellular and molecular processes, the presence of apoptotic processes was observed in all the 3 groups, while anti-apoptotic processes only existed in the 3 h and 12 h groups, not in the 24 h group.Figure 3**Top ten process networks in 3 h, 12 h, and 24 h groups after cerebral ischemia-reperfusion injury.** The red, blue, and green circles represent the process networks in the 3 h, 12 h, and 24 h groups, respectively.

The dynamic change in apoptosis stimulation by external signals at 3 h, 12 h, and 24 h {#Sec17}
--------------------------------------------------------------------------------------

The process of apoptosis stimulation by external signals was consistently activated at all the three time points. It was the top-scored process in the 3 h and 12 h groups, but the fourth-scored process in the 24 h group. Three overlapping differentially expressed genes were identified among the three groups. Two, 2, and 1 overlapping genes were detected in paired groups of 3 h and 12 h, 12 h and 24 h, and 3 h and 24 h, respectively (Figure [4](#Fig4){ref-type="fig"}). A total of 0, 2, and 2 non-overlapping differentially expressed genes were identified in the 3 h, 12 h, and 24 h groups, respectively.Figure 4**Changes in process of apoptosis stimulation by external signals in 3 h, 12 h and 24 h groups after cerebral ischemia-reperfusion injury.** The target with red, blue, and green circles represent the process networks in the 3 h, 12 h, and 24 h groups, respectively.

Network analysis in 3 h, 12 h, and 24 h groups {#Sec18}
----------------------------------------------

In total, 35, 51, 53 genes and related molecules constituted the networks in the 3 h, 12 h, and 24 h groups, respectively. A total of 6, 10, and 16 non-overlapping/unique genes and related molecules were identified in the 3 h, 12 h, and 24 h group networks, respectively. Nineteen overlapping genes and related molecules were identified among the three group networks. Seven, 15, 3 overlapping genes and related molecules were detected between the 3 h and 12 h groups, 12 h and 24 h groups, and 3 h and 24 h groups, respectively (Figure [5](#Fig5){ref-type="fig"}).Figure 5**Networks in 3 h, 12 h, and 24 h groups after cerebral ischemia-reperfusion injury. a)**, **b)**, and **c)** represent the networks in the 3 h, 12 h, and 24 h groups, respectively. **d)** represents the number of overlapping and non-overlapping genes and related molecules in the 3 h, 12 h, and 24 h groups.

Node degree analysis of network {#Sec19}
-------------------------------

Several nodes were found to be linked with each other. The node whose degree is equal to or greater than 3 is listed in Table [1](#Tab1){ref-type="table"}. Amongst the genes or proteins with a node degree \>3, Pyk2, PKC, E2F1, VEGF-A, GATA-2, and Vimentin have already been reported to be related with ischemia-reperfusion injury; however, others such as E2A/HLF fusion protein, TFIID, GRB2, and RAR have not been reported previously.Table 1**Important gene node list at 3 h, 12 h, and 24 h (degree ≥ 3)TimeNodeDegreeReferences**3 hPyk2(FAK2)3\[[@CR20]\]12 hPKC9\[[@CR21]\]E2F16\[[@CR22]\]E2A/HLF fusion protein4------VEGF-A4\[[@CR23]\]Cyclin A3\[[@CR24]\]E2F33\[[@CR25]\]Vimentin3\[[@CR26]\]RAR3------24 hPKC9\[[@CR21]\]E2A/HLF fusion protein4------VEGF-A3\[[@CR23]\]TFIID3------GRB23------

Jaccard similarity analysis of network {#Sec20}
--------------------------------------

The Jaccard similarity index emphasizes the difference of molecular expression at different time points \[[@CR27]\]. The Jaccard index for the network level comparison between 3 h and 12 h, 12 h and 24 h, and 3 h and 24 h was calculated to be 0.41, 0.45, and 0.30, respectively, demonstrating a higher level of similarity between 12 h and 24 h than that between 3 h and 12 h. This indicated that the molecular change rate from 3 h to12 h was higher than that from 12 h to 24 h.

Discussion {#Sec21}
==========

To probe the mechanism of ischemia-reperfusion injury, we used the Metacore™ software to analyze the overlapping and non-overlapping pathways as well as cellular and molecular network processes, and reconstructed networks at 3 h, 12 h, and 24 h post injury. The number of activated pathways and cellular and molecular processes at different time points was found to be quite different.

Several common and unique pathways were observed in the 3 h, 12 h, and 24 h groups. A literature review about ischemia-reperfusion injury revealed a close relationship with 21 pathways across time points post injury \[[@CR28]-[@CR42]\], but G-protein signaling_TC21 regulation pathway that was activated at 24 h has not been previously reported to have a direct relationship with ischemia-reperfusion injury. Studies on the TC21 regulation pathway mostly focused on its role in cancer, which mediates its effects via the PI3K-Akt pathway, NF-κB, and cyclin D1 that are all related with cerebral ischemia reperfusion injury \[[@CR43]\]. This may be the reason why it has a higher degree in cerebral I-R, and more attention needs to be focused on the role of the TC21 regulation pathway in cerebral I-R.

Changes in six pathways over time were not consistent with those reported in previous studies, including those involved in cytoplasmic/mitochondrial transport of proapoptotic proteins Bid, Bmf, and Bim, FAS signaling cascades, activation of Erk by ACM1, ACM3, and ACM5, VEGF signaling via VEGFR2-generic cascades, MDA-dependent postsynaptic long-term potentiation in CA1 hippocampal neurons, and G-protein mediated regulation of MARK-ERK signaling. In previous studies, these pathways were reported to be expressed at all observed time points \[[@CR44]-[@CR48]\]. The disparity between our findings and previously published data may be resulted from the use of different models, different observed time points, different genes, or different tissues.

According to enrichment analysis of pathways at different time points, signal transduction, immune response, and apoptosis were identified as the main molecular processes in the 3 h, 12 h, and 24 h groups. However, several differences were observed amongst these three time points. At 3 h, extracellular signals binded to cognate receptors, initiating the immune response. At 12 h, apoptosis was triggered by the differential expression of several pathways, as a result of activation by enzymes and signal transduction. At 24 h, more pathways were activated, especially the G-protein coupled receptor protein signaling pathway (Figure [6](#Fig6){ref-type="fig"}).Figure 6**Visualized dynamic change in the course of pathways at 3 h, 12 h, and 24 h.** Squares filled with color represent the receptor, while ovals represent the pathway. The content not within squares or ovals represents a pathway that is related to a pathway activated in our study. Squares not filled with any color represent a biological function. The red-, blue-, and green-colored squares or ovals represent 3 h, 12 h, and 24 h after cerebral ischemia-reperfusion injury, respectively.

Process network analysis revealed that apoptotic and anti-apoptotic pathways existed in both 3h and 12h groups, consistent with the findings from a previous study \[[@CR49]\]. Our study also found that apoptosis existed in the top 10 processes at 24 h, whereas anti-apoptotic process was absent. Both apoptotic and anti-apoptotic processes might determine the prognosis of injured neurons. Perhaps at 24 h after injury, the anti-apoptotic process was weakened while apoptosis played a leading role, and therefore cell death reached a peak at 24 h post injury. These results demonstrate that early treatment that may activate the process of anti-apoptosis within 12 h has the potential to decrease cell death. This observation is also supported by other study findings. Bcl-xL, belonging to Bcl-2 family, can inhibit cell death \[[@CR49]\]. It was differentially expressed at 3 h and 12 h, but not at 24 h, as revealed by analyzing the process of apoptosis stimulation by external signals, which was a pathway common to all three time points. This role of inhibition of anti-apoptotic processes remains to be elucidated.

Based on published literature \[[@CR50]-[@CR52]\], a minority of nodes in a large variety of real world networks is a hub, i.e. a node having a much higher number of neighbors. Hub nodes are important components for shared networks, providing more information than non-hub nodes. The degree is a factor to evaluate the hub node, and a higher degree represents a more important node \[[@CR53],[@CR54]\]. By analyzing the node degree in the network at different time points, Pyk2 (FAK2) and PKC were identified to be the most important nodes in the 3h, 12h and 24h groups. Pyk2 (FAK2) and PKC, the important proteins in PLC/PKC/Pyk2/Src signaling pathway, can enhance NMDA receptor function in hippocampal neurons \[[@CR55]\], and NMDA receptor may lead to Ca^2+^ internal flow, resulting in cerebral ischemic reperfusion \[[@CR56]\]. However, other nodes including E2A/HLF fusion protein, TFIID, and GRB2 have never been implicated in the pathogenesis of I-R previously and merit further investigation to understand their functions. Prior studies on E2A/HLF fusion protein mainly focused on its relationship to leukemia; in the context of leukemia, it may induce T-cell apoptosis, and is considered as an very important protein \[[@CR57]\]. Besides, TFIID plays a critical role in RNA polymerase II (Pol II) pre-initiation complex (PIC) formation, and therefore, it may affect the process of transcription during cerebral I-R \[[@CR58]\]. The relationship between GRB2 and cerebral I-R may be owed to GRB-2-associated binder 1 (Gab1), which is essential in preventing against I-R oxidative injury via mediating survival signaling \[[@CR59]\].

Overall, most of earlier studies limited their analysis to a detailed investigation of just a few pathways; while our study provides a comprehensive report of the time course of a differential gene expression profile at 3 h, 12 h, and 24 h post cerebral ischemia injury. Being a method of systematic analysis, it allows for observing changes across 22 different pathways at each time point. Such a method can aid in identifying new important pathways, genes, proteins, or cellular processes by tracking dynamic changes over the course of pathogenesis. One caveat of this method is its limitation in further in-depth study of a specific pathway. Another limitation is that we only observe the changes in gene expression, which may miss post-translational mechanisms. Based on the findings of this study, we propose an in-depth experimental analysis of a few candidate pathways.

Conclusions {#Sec22}
===========

Overlapping and non-overlapping pathways and networks demonstrate the sequential changes in the course of molecular pathways in the hippocampus of ischemic mice. Based on our data, we propose a hypothesis that early treatment which can activate the process of anti-apoptosis within 12 h is essential for decreasing cell death; and this hypothesis should be verified further. To our knowledge, this is the first study to identify one pathway and three genes implicated in cerebral I-R, the roles of which need to be elucidated to understand the pathology of ischemic damages.
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